€0.00
MEGGLE – high quality crystalline lactose producers, designed for DPIs
MEGGLE has developed a specialty lactose grade, InhaLac®, to help meet the challenges associated with dry powder inhalation (DPI).
Inhalation aerosols offers the potential for needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins. An industry standard in dry power inhalation formulation development, lactose monohydrate is used safely in DPI formulations. Using lactose as an excipient not only improves performance efficiency of the inhaler, but also facilitates powder handling during production. Effective performance of a dry powder inhaler largely depends on the carrier material used for the drug formulation.
With our highly controlled production process different high quality sieved and milled grades are obtained, providing an adequate range of particle sizes – making them behave as individual particles.
Please call or email one of our experts – we are always ready to help.
Phone: +49 (0) 8071-73-476
Shelf life / Retest:
24 months
Standard Packaging:
25 kg – Carton box with double PE-EVOH-PE Inliner
Particle size distribution [Laser diffraction]
Typical Values
Benefits
Areas of Application
With InhaLac®, MEGGLE can offer customized milled and sieved fractions – specifically and efficiently prepared to meet your DPI formulation needs.
| Manufacturer |
Meggle |
|---|---|
| Quality |
EP, JP, USP/NF |
| Cas-No |
5989-81-1 |
| Composition |
Lactose for Inhalation |
| Dosage Form |
Inhalation |
| Function |
Used for Dry Powder Inhaler formulations |
InhaLac 400€0.00 |
Meggle | Select options This product has multiple variants. The options may be chosen on the product page |
InhaLac 500€0.00 |
Meggle | Select options This product has multiple variants. The options may be chosen on the product page |
